Technical Analysis for AZN - Astrazeneca Plc

Grade Last Price % Change Price Change
F 10290.00 -0.04% -4.00
AZN closed down 0.04 percent on Monday, March 18, 2024, on 1.35 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Flat

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
NR7 Range Contraction 0.00%
Gapped Up Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 50 DMA Bearish -0.04%
Overbought Stochastic Strength -0.04%
Stochastic Sell Signal Bearish -1.08%
NR7 Range Contraction -1.08%
Inside Day Range Contraction -1.08%
Overbought Stochastic Strength -1.08%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 16 hours ago
Gap Up Closed about 21 hours ago
Reversed from Up about 21 hours ago
Gap Up Partially Closed about 21 hours ago
Fell Below Previous Day's Low about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Astrazeneca Plc Description

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVMD, it is expanding its portfolio into the cardiovascular-renal area with late-stage assets, such as ZS-9 and roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). The Company has approximately 40 projects in Phase I, including 29 new molecular entities (NMEs), and 11 oncology combination projects. It has approximately 40 projects in Phase II, including 25 NMEs; four significant additional indications for projects that have reached phase II, and seven oncology combination projects.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Pharmaceutical Natural Sciences Science Life Sciences Disease Biopharmaceutical Oncology Pharmacy Pharmaceutical Industry Therapy Franchises Infection Respirator Therapies E Card Molecular Astrazeneca Neuroscience Heart Failure Kidney Disease Chronic Kidney Disease Södertälje Municipality

Is AZN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12389.2908
52 Week Low 9461.5387
Average Volume 2,730,015
200-Day Moving Average 10602.86
50-Day Moving Average 10316.74
20-Day Moving Average 10222.09
10-Day Moving Average 10301.20
Average True Range 177.55
RSI (14) 51.69
ADX 10.97
+DI 26.21
-DI 25.73
Chandelier Exit (Long, 3 ATRs) 10001.34
Chandelier Exit (Short, 3 ATRs) 10354.66
Upper Bollinger Bands 10500.44
Lower Bollinger Band 9943.75
Percent B (%b) 0.62
BandWidth 5.45
MACD Line 36.78
MACD Signal Line 8.96
MACD Histogram 27.8181
Fundamentals Value
Market Cap 159.51 Billion
Num Shares 1.55 Billion
EPS 3.02
Price-to-Earnings (P/E) Ratio 3407.28
Price-to-Sales 3.32
Price-to-Book 4.88
PEG Ratio 0.47
Dividend 2.90
Dividend Yield 0.03%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10440.00
Resistance 3 (R3) 10440.00 10390.00 10415.00
Resistance 2 (R2) 10390.00 10351.80 10390.00 10406.66
Resistance 1 (R1) 10340.00 10328.20 10315.00 10340.00 10398.33
Pivot Point 10290.00 10290.00 10277.50 10290.00 10290.00
Support 1 (S1) 10240.00 10251.80 10215.00 10240.00 10181.67
Support 2 (S2) 10190.00 10228.20 10190.00 10173.34
Support 3 (S3) 10140.00 10190.00 10165.00
Support 4 (S4) 10140.00